A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis

Gastroenterology

Volumn 117, Issue 5, 1999, Pages 1173-1180

  Kaplan, M M ^a   Schmid, C ^a   Provenzale, D ^a   Sharma, A ^a   Dickstein, G ^a   McKusick, A ^a  

^a Box 233   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; COLCHICINE; IMMUNOGLOBULIN G; METHOTREXATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0032716062     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70403-8     Document Type: Article

References (29)

1. MM Kaplan Primary biliary cirrhosis (review) N Engl J Med 335 1996 1570 1578
2. RE Poupon R Poupon B Balkau Ursodiol for the long-term treatment of primary biliary cirrhosis N Engl J Med 330 1994 1342 1347
3. EJ Heathcote K Cauch-Dudek V Walker RJ Bailey LM Blendis CN Ghent P Michieletti GY Miuuk SC Pappas LI Scully The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 19 1994 1149 1156
4. KD Lindor ER Dickson WP Baldus RA Jorgensen J Ludwig PA Murtaugh JM Harrison RH Wiesner ML Anderson SM Lange Ursodeoxycholic acid in the treatment of primary biliary cirrhosis Gastroenterology 106 1994 1284 1290
5. B Combes RL Carithers WC Maddrey D Lin MF McDonald DE Wheeler EH Eigenbrodt SJ Munoz R Rubin G Garcia-Tsao A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 22 1995 759 766
6. MM Kaplan DW Alling HJ Zimmerman HJ Wolfe RA Sepersky GS Hirsch GH Elta KA Glick KA Eagen A prospective trial of colchicine for primary biliary cirrhosis N Engl J Med 315 1986 1448 1454
7. MM Kaplan TA Knox Treatment of primary biliary cirrhosis with low-dose weekly methotrexate Gastroenterology 101 1991 1332 1338
8. NV Bergasa A Jones DE Kleiner L Rabin Y Park MC Wells Hoofnagle. Pilot study of low-dose oral methotrexate treatment for primary biliary cirrhosis Am J Gastroenterol 91 1996 295 299
9. TW Warnes A Smith FI Lee NY Haboubi PJ Johnson L Hunt A controlled trial of colchicine in primary biliary cirrhosis J Hepatol 5 1987 1 7
10. H Bodenheimer Jr F Schaffner J Pezzullo Evaluation of colchicine therapy in primary biliary cirrhosis Gastroenterology 95 1988 124 129
11. M Vuoristo M Farkkila AL Karvonen R Leino J Lehtola J Makinen J Mattila C Friman K Seppala J Tuominen TA Miettinen A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid Gastroenterology 108 1995 1470 1478
12. A Zifroni F Schaffner Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy Hepatology 14 1991 990 993
13. MM Kaplan TA Knox SA Arora Primary biliary cirrhosis treated with low-dose oral pulse methotrexate Ann Intern Med 109 1988 429 431
14. MM Kaplan TA Knox Methotrexate for primary biliary cirrhosis (letter) Gastroenterology 102 1992 1824
15. RE Poupon B Balkau E Eschwege R Poupon A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis N Engl J Med 324 1991 1548 1554
16. PJ Scheuer Primary biliary cirrhosis: diagnosis, pathology and pathogenesis Postgrad Med J 4 1983 106 115
17. GR Locke TM Therneau J Ludwig ER Dickson KD Lindor Time course of histological progression in primary biliary cirrhosis Hepatology 23 1996 52 56
18. ER Dickson PM Grambsch TR Fleming LD Fisher A Langworthy Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 111 113
19. C Degott ES Zafrani P Callard B Balkau RE Poupon R Poupon Histopathogical study of primary biliary cirhhosis and the effect of ursodeoxycholic acid treatment on histology progression Hepatology 29 1999 1007 1012
20. M Kaplan R DeLellis H Wolfe Sustained biochemical and histological remission of primary biliary cirrhosis in response to medical treatment Ann Intern Med 126 1997 682 688
21. PAL Bonis M Kaplan Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol Gastroenterology 117 1999 395 399
22. RA Jorgensen ER Dickson AF Hofmann SS Rossi KD Lindor Characterisation of patients with a complete biochemical response to ursodeoxycholic acid Gut 36 1995 935 938
23. A Sharma D Provenzale A McKusick MM Kaplan Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis Gastroenterology 107 1994 266 270
24. S Munoz RL Carithers SS Emmerson N Five B Combes Group ftP Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol (abstr) Hepatology 28 1998 392
25. H Zachariae H Sogaard Methotrexate-induced liver cirrhosis: a follow-up Dermatologica 175 1987 178 182
26. MM Kaplan Methotrexate hepatotoxicity and the premature reporting of Mark Twain's death: both greatly exaggerated Hepatology 12 1990 784 786
27. BH Markus ER Dickson PM Grambsch TR Fleming V Mazzafero GB Klintmalm RH Wiesner DH Van Thiel TE Starzl Efficiency of liver transplantation in patients with primary biliary cirrhosis N Engl J Med 320 1989 1709 1713
28. BM Goudie AD Burt GJ Macfarlane P Boyle CR Gillis RN MacSween G Watkinson Risk factors and prognosis in primary biliary cirrhosis Am J Gastroenterol 84 1989 713 716
29. MM Kaplan New strategies needed for treatment of primary biliary cirrhosis? Gastroenterology 104 1993 651 653